Dr. Prockop Discusses Tabelecleucel In Post-Transplant Ebv+ Lymphomas

Dr. Prockop Discusses Tabelecleucel in Post-Transplant EBV+ Lymphomas

Tabelecleucel in the treatment of EBV+ PTLD

VJHemOnc – Video Journal of Hematology & HemOnc

Long-term outcomes of subjects with EBV driven PTLD following solid organ or allogeneic HCT trea...

Strategies for the management of EBV-PTLD

VJHemOnc – Video Journal of Hematology & HemOnc

Tabelecleucel in EBV-associated PTLD

Tab-cel for solid organ or allogeneic transplant recipients with EBV-PTLD

VJHemOnc – Video Journal of Hematology & HemOnc

The treatment and management of PTLD

VJHemOnc – Video Journal of Hematology & HemOnc

Epstein-Barr virus associated post-transplant lymphoproliferative disorder (EBV+ PTLD)

Rituximab induction is a predictive biomarker in post-transplant lymphoproliferative disorder

Tabelecleucel as an alternative treatment option in patients following transplantation

VJHemOnc – Video Journal of Hematology & HemOnc

Atara Biotherapeutics

Alliance for Regenerative Medicine

T-Cell Therapies - Catherine Bollard, MD | Pediatric Grand Rounds

David Geffen School of Medicine at UCLA

Improving virus-specific T-cell therapy

VJHemOnc – Video Journal of Hematology & HemOnc

The use of viral-specific T-cells post bone marrow transplantation

VJHemOnc – Video Journal of Hematology & HemOnc

How Long Do Kidney Transplants Last? | #Shorts

Mass General Brigham

Get to know transplant hepatologist Dr. Matthew Cave

Reasons for Biopsies After Transplant | Liver Transplant | UCHealth

What is The Importance of Follow-up After a Kidney Transplant?

Prof. Barış Akin

Panel Discussion: Perspectives from Pancreatic Cancer Survivors And Caregivers 2022

HirshbergFoundation

Managing patients with transplant-ineligible BDPCN with tagraxofusp

VJHemOnc – Video Journal of Hematology & HemOnc